Brian Posner
Board Member
Dyne Therapeutics, Inc. (DYN)Equibles does not estimate personal net worth.
Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DYN alertsAbout Brian Posner
Brian Posner is recorded as Board Member at Dyne Therapeutics, Inc. (DYN) since October 1, 2025. Dyne Therapeutics, Inc. reported in an 8-K filed October 2, 2025 that Brian Posner was appointed Class III director, effective October 1, 2025. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John Cox (CEO and Board Member), John G. Cox (CEO and Board Member), Josh Brumm (CEO) and 4 others.
“On October 1, 2025, the Board of Directors (the "Board") of Dyne Therapeutics, Inc. (the "Company"), upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Brian Posner as a Class III director to serve on the Board until the Company's 2026 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.”
Affiliation history
-
Current
2025-10-01–present
Company network
Leadership on record at Dyne Therapeutics, Inc.
- John Cox CEO, Board Member
- John G. Cox CEO, Board Member
- Josh Brumm CEO
- Erick Lucera CFO, Chief Accounting Officer
- Barry E. Greene Board Member
- Carlo Incerti, M.D. Board Member
- Vikram Karnani Board Member